Transarterial yttrium-90 radioembolization (TARE) blended with 2nd-line chemotherapy improved progression-free survival (PFS) in sufferers with unresectable colorectal cancer liver metastases, in response to results from…
Transarterial yttrium-90 radioembolization (TARE) blended with 2nd-line chemotherapy improved progression-free survival (PFS) in sufferers with unresectable colorectal cancer liver metastases, in response to results from…